6Y14

Bicyclic peptide bp65 crystallized as racemic mixture at 0.9 Angstrom resolution


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 0.90 Å
  • R-Value Work: 0.126 
  • R-Value Observed: 0.191 

wwPDB Validation   3D Report Full Report


This is version 2.1 of the entry. See complete history


Literature

A mixed chirality alpha-helix in a stapled bicyclic and a linear antimicrobial peptide revealed by X-ray crystallography.

Baeriswyl, S.Personne, H.Di Bonaventura, I.Kohler, T.van Delden, C.Stocker, A.Javor, S.Reymond, J.L.

(2021) RSC Chem Biol 2: 1608-1617

  • DOI: https://doi.org/10.1039/d1cb00124h
  • Primary Citation of Related Structures:  
    6Y0U, 6Y0V, 6Y13, 6Y14, 6Y1S, 7NEF, 7NEW

  • PubMed Abstract: 

    The peptide α-helix is right-handed when containing amino acids with l-chirality, and left-handed with d-chirality, however mixed chirality peptides generally do not form α-helices unless a helix inducer such as the non-natural residue amino-isobutyric acid is used. Herein we report the first X-ray crystal structures of mixed chirality α-helices in short peptides comprising only natural residues as the example of a stapled bicyclic and a linear membrane disruptive amphiphilic antimicrobial peptide (AMP) containing seven l- and four d-residues, as complexes of fucosylated analogs with the bacterial lectin LecB. The mixed chirality α-helices are superimposable onto the homochiral α-helices and form under similar conditions as shown by CD spectra and MD simulations but non-hemolytic and resistant to proteolysis. The observation of a mixed chirality α-helix with only natural residues in the protein environment of LecB suggests a vast unexplored territory of α-helical mixed chirality sequences and their possible use for optimizing bioactive α-helical peptides.


  • Organizational Affiliation

    Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern Freiestrasse 3 3012 Bern Switzerland jean-louis.reymond@unibe.ch.


Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  

Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
bp65
A, B
13synthetic constructMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 0.90 Å
  • R-Value Work: 0.126 
  • R-Value Observed: 0.191 
  • Space Group: P -1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 16.482α = 111.28
b = 26.209β = 92.26
c = 29.909γ = 101.96
Software Package:
Software NamePurpose
XDSdata reduction
XSCALEdata scaling
SHELXphasing
SHELXrefinement
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Swiss National Science FoundationSwitzerland--

Revision History  (Full details and data files)

  • Version 1.0: 2021-02-17
    Type: Initial release
  • Version 1.1: 2021-03-03
    Changes: Database references
  • Version 1.2: 2021-08-04
    Changes: Database references
  • Version 1.3: 2022-02-02
    Changes: Database references
  • Version 2.0: 2023-02-01
    Changes: Advisory, Atomic model, Data collection, Database references, Derived calculations, Polymer sequence, Source and taxonomy, Structure summary
  • Version 2.1: 2024-10-23
    Changes: Data collection, Derived calculations, Structure summary